"10.1371_journal.pone.0065893","plos one","2013-06-14T00:00:00Z","Sabine Frank; Martin Heni; Anja Moss; Julia von Schnurbein; Sadaf Farooqi; Hans-Ulrich Häring; Andreas Fritsche; Hubert Preissl; Martin Wabitsch","Institute of Medical Psychology and Behavioral Neurobiology, fMEG Center, University of Tübingen, Tübingen, Germany; Department of Internal Medicine IV, University Hospital, Tübingen, Germany; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany; German Center for Diabetes Research, Neuherberg, Germany; Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University of Ulm, Ulm, Germany; Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, University of Cambridge, Cambridge, United Kingdom","Conceived and designed the experiments: S. Frank MH AM HUH AF HP MW. Performed the experiments: S. Frank MH AM JvS. Analyzed the data: S. Frank MH AM. Wrote the paper: S. Frank MH JvS HP MW. Critical revision of the manuscript: AM S. Farooqi HUH AF. Interpretation of data: AM S. Farooqi HUH AF.","Amylin Pharmaceuticals, LLC (San Diego, USA) provided metreleptin for this patient under compassionate use provisions. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","06","Sabine Frank","SF",9,TRUE,1,1,1,1,TRUE,TRUE,TRUE,5,"2;6;7;8;9",TRUE
